HomeInsightsStock Comparison

Ajanta Pharma Ltd vs Ang Lifesciences India Ltd Stock Comparison

Ajanta Pharma Ltd vs Ang Lifesciences India Ltd Stock Comparison

Last Updated on: Sep 13, 2025

Key Highlights

  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2578 as of 12 Sep 15:30.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 25.6 on March 2020 to 35.7 on March 2025 . This represents a CAGR of 5.70% over 6 yearsThe P/E Ratio of ANG Lifesciences India Ltd changed from 6 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 11921 crore on March 2020 to ₹ 32708 crore on March 2025 . This represents a CAGR of 18.32% over 6 yearsThe Market Cap of ANG Lifesciences India Ltd changed from ₹ 243.2 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 4 years.
  • The revenue of Ajanta Pharma Ltd for the Jun '25 is ₹ 1328 crore as compare to the Mar '25 revenue of ₹ 1188 crore. This represent the growth of 11.82% The revenue of ANG Lifesciences India Ltd for the Jun '25 is ₹ 24.69 crore as compare to the Mar '25 revenue of ₹ 17.47 crore. This represent the growth of 41.33%.
  • The ebitda of Ajanta Pharma Ltd for the Jun '25 is ₹ 377.68 crore as compare to the Mar '25 ebitda of ₹ 315.26 crore. This represent the growth of 19.8% The ebitda of ANG Lifesciences India Ltd for the Jun '25 is ₹ 0.73 crore as compare to the Mar '25 ebitda of ₹ -0.05 crore. This represent the decline of -1560%.
  • The net profit of Ajanta Pharma Ltd changed from ₹ 208.12 crore to ₹ 255.34 crore over 9 quarters. This represents a CAGR of 9.51% The net profit of ANG Lifesciences India Ltd changed from ₹ 1.75 crore to ₹ -2.01 crore over 9 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Ajanta Pharma Ltd changed from 25.99 % on March 2020 to 38.28 % on March 2025 . This represents a CAGR of 6.67% over 6 yearsThe Dividend Payout of ANG Lifesciences India Ltd changed from 2.61 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma Limited is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About ANG Lifesciences India Ltd

  • ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006.
  • On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010.
  • The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010.
  • Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials.
  • In 2008-09, the Company started its commercial production.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma Ltd up for third straight session

Ajanta Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 258...

Read more

04 Sep 2025 13:05

News

Ajanta Pharma Ltd drops for fifth straight session

Ajanta Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 2587...

Read more

26 Aug 2025 13:35

News

Ajanta Pharma Ltd down for fifth straight session

Ajanta Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs 2...

Read more

05 Aug 2025 13:35

News

Ajanta Pharma allots 23,525 equity shares under ESOP

Ajanta Pharma has allotted 23,525 equity shares under ESOP on 28 July 2025. In view of the...

Read more

28 Jul 2025 18:51

News

Ajanta Pharma to convene board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 28 July 2025...

Read more

17 Jul 2025 10:29

News

Ajanta Pharma Ltd spurts 0.96%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2814...

Read more

17 Jul 2025 13:00

ANG Lifesciences India Ltd News Hub

News

ANG Lifesciences India to convene board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

07 Aug 2025 11:25

News

ANG Lifesciences India to hold board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

24 May 2025 11:24

News

ANG Lifesciences India Ltd leads losers in 'B' group

Adroit Infotech Ltd, Dynamic Cables Ltd, Archidply Decor Ltd and Kwality Pharmaceuticals L...

Read more

20 Mar 2025 14:46

News

ANG Lifesciences India schedules board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

07 Feb 2025 17:09

News

ANG Lifesciences India to conduct board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

11 Nov 2024 13:04

News

ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 2024 17:50

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of ANG Lifesciences India Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for ANG Lifesciences India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ajanta Pharma Ltd and ANG Lifesciences India Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or ANG Lifesciences India Ltd?

Market cap of Ajanta Pharma Ltd is 32,215 Cr while Market cap of ANG Lifesciences India Ltd is 42 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and ANG Lifesciences India Ltd?

The stock performance of Ajanta Pharma Ltd and ANG Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and ANG Lifesciences India Ltd?

As of September 13, 2025, the Ajanta Pharma Ltd stock price is INR ₹2578.55. On the other hand, ANG Lifesciences India Ltd stock price is INR ₹32.67.

How do dividend payouts of Ajanta Pharma Ltd and ANG Lifesciences India Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and ANG Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions